查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1556601

免疫測量(RIA) 市場報告：2030 年趨勢、預測與競爭分析

Radioimmunoassay (RIA) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

免疫測量(RIA) 趨勢與預測

2024年至2030年，全球免疫測量（免疫檢測）市場預計將以3.2%的複合年成長率成長。該市場的主要驅動力是癌症發病率的增加、醫療保健自動化需求的不斷成長以及醫學研究的進步。全球免疫測量(RIA) 市場的未來看起來充滿希望，醫院、製藥、學術和臨床診斷實驗室市場都充滿機會。

免疫測量（RIA）細分市場預測

本研究包括按類型、應用、最終用途和區域對全球免疫測量(RIA) 進行預測。

免疫測量(RIA) 市場洞察

Lucintel 預計試劑和套件在預測期內將出現高速成長。

在這個市場中，臨床實驗室最受歡迎，因為該設施中免疫測量的利用率很高，因為它們能夠以高通量、高靈敏度和高特異性分析生物樣本中的各種分析物，預計會出現高成長。

由於有利的報銷政策和強大的醫療保健系統的存在，北美在預測期內可能仍然是最大的地區。

常問問題

Q1.市場成長預測是多少：

A1. 2024 年至 2030 年，全球免疫測量(RIA) 市場預計將以 3.2% 的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 該市場的主要驅動力是癌症發生率的增加、醫療保健自動化需求的成長以及醫學研究的進步。

Q3.市場的主要細分市場是：

A3.免疫測量(RIA) 市場的未來前景廣闊，在醫院、製藥、學術和臨床實驗室市場都有機會。

Q4.市場的主要企業是：

A4.免疫測量（RIA）的主要企業如下：

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預計試劑和套件在預測期內將出現高速成長。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 由於有利的報銷政策和強大的醫療保健系統的存在，北美在預測期內將繼續成為最大的地區。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球免疫測量（RIA）市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球免疫測量（RIA）市場趨勢（2018-2023）與預測（2024-2030）
  • 全球免疫測量(RIA) 市場（按類型）
    • 試劑/套件
    • 分析儀
  • 全球免疫測量（RIA）市場（按應用）
    • 臨床診斷
    • 研究
  • 按最終用途分類的全球免疫測量(RIA) 市場
    • 醫院
    • 製藥
    • 學術的
    • 臨床實驗室
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球免疫測量(RIA) 市場：按地區
  • 北美免疫測量（RIA）市場
  • 歐洲免疫測量（RIA）市場
  • 亞太地區放射免疫測量（RIA）市場
  • 其他地區免疫測量（RIA）市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球免疫測量(RIA) 市場的成長機會（按類型）
    • 全球免疫測量(RIA) 市場成長機會（按應用）
    • 按最終用途分類的全球免疫測量(RIA) 市場成長機會
    • 按地區分類的全球免疫測量(RIA) 市場成長機會
  • 全球免疫測量(RIA) 市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球免疫測量(RIA) 市場的產能擴張
    • 全球免疫測量(RIA) 市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore
簡介目錄

Radioimmunoassay (RIA) Trends and Forecast

The future of the global radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets. The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030. The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Radioimmunoassay (RIA) by Segment

The study includes a forecast for the global radioimmunoassay (RIA) by type, application, end use, and region.

Radioimmunoassay (RIA) Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents & Kits
  • Analyzers

Radioimmunoassay (RIA) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Clinical Diagnostics
  • Research

Radioimmunoassay (RIA) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Pharmaceuticals
  • Academics
  • Clinical Diagnostic Laboratories
  • Others

Radioimmunoassay (RIA) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Radioimmunoassay (RIA) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radioimmunoassay (RIA) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radioimmunoassay (RIA) companies profiled in this report include-

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore

Radioimmunoassay (RIA) Market Insights

Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.

Within this market, clinical diagnostic laboratory is expected to witness the highest growth due to substantial usage of radioimmunoassay in this facility given to their ability to analyze a broad variety of analytes in biological samples with high throughput, high sensitivity, and specificity.

North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.

Features of the Global Radioimmunoassay (RIA) Market

Market Size Estimates: Radioimmunoassay (RIA) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Radioimmunoassay (RIA) market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Radioimmunoassay (RIA) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the radioimmunoassay (RIA) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radioimmunoassay (RIA) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for radioimmunoassay (RIA) market?

Answer: The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the radioimmunoassay (RIA) market?

Answer: The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.

Q3. What are the major segments for radioimmunoassay (RIA) market?

Answer: The future of the radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets.

Q4. Who are the key radioimmunoassay (RIA) market companies?

Answer: Some of the key radioimmunoassay (RIA) companies are as follows:

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore

Q5. Which radioimmunoassay (RIA) market segment will be the largest in future?

Answer: Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.

Q6. In radioimmunoassay (RIA) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the radioimmunoassay (RIA) market by type (reagents & kits and analyzers), application (clinical diagnostics and research), end use (hospitals, pharmaceuticals, academics, clinical diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Radioimmunoassay (RIA) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Radioimmunoassay (RIA) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Radioimmunoassay (RIA) Market by Type
    • 3.3.1: Reagents & Kits
    • 3.3.2: Analyzers
  • 3.4: Global Radioimmunoassay (RIA) Market by Application
    • 3.4.1: Clinical Diagnostics
    • 3.4.2: Research
  • 3.5: Global Radioimmunoassay (RIA) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Pharmaceuticals
    • 3.5.3: Academics
    • 3.5.4: Clinical Diagnostic Laboratories
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Radioimmunoassay (RIA) Market by Region
  • 4.2: North American Radioimmunoassay (RIA) Market
    • 4.2.1: North American Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.2.2: North American Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
  • 4.3: European Radioimmunoassay (RIA) Market
    • 4.3.1: European Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.3.2: European Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
  • 4.4: APAC Radioimmunoassay (RIA) Market
    • 4.4.1: APAC Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.4.2: APAC Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
  • 4.5: ROW Radioimmunoassay (RIA) Market
    • 4.5.1: ROW Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.5.2: ROW Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Type
    • 6.1.2: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Application
    • 6.1.3: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Region
  • 6.2: Emerging Trends in the Global Radioimmunoassay (RIA) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Radioimmunoassay (RIA) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radioimmunoassay (RIA) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: DiaSource ImmunoAssays
  • 7.2: Beckman Coulter
  • 7.3: IBL International
  • 7.4: PerkinElmer
  • 7.5: DRG International
  • 7.6: MP Biomedicals
  • 7.7: Cisbio
  • 7.8: Euro Diagnostica
  • 7.9: DiaSorin
  • 7.10: EMD Millipore